328 related articles for article (PubMed ID: 16431395)
1. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
[TBL] [Abstract][Full Text] [Related]
2. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
Reza MS; Quadir MA; Haider SS
J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
[TBL] [Abstract][Full Text] [Related]
4. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
5. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
Emeje MO; Kunle OO; Ofoefule SI
Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
[TBL] [Abstract][Full Text] [Related]
6. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
[TBL] [Abstract][Full Text] [Related]
7. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
[TBL] [Abstract][Full Text] [Related]
8. Surelease as granulating liquid in preparation of sustained release matrices of ethylcellulose and theophylline.
Afrasiabi Garekani H; Faghihnia Torshizi M; Sadeghi F
Drug Dev Ind Pharm; 2015; 41(10):1655-60. PubMed ID: 25402967
[TBL] [Abstract][Full Text] [Related]
9. Release characteristics of the matrices prepared from co-spray-dried powders of theophylline and ethylcellulose.
Kulvanich P; Leesawat P; Patomchaiviwat V
Drug Dev Ind Pharm; 2002 Jul; 28(6):727-39. PubMed ID: 12149966
[TBL] [Abstract][Full Text] [Related]
10. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
Obeidat WM; Alzoubi NM
Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
[TBL] [Abstract][Full Text] [Related]
11. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
[TBL] [Abstract][Full Text] [Related]
12. Compression forces and amount of outer coating layer affecting the time-controlled disintegration of the compression-coated tablets prepared by direct compression with micronized ethylcellulose.
Lin KH; Lin SY; Li MJ
J Pharm Sci; 2001 Dec; 90(12):2005-9. PubMed ID: 11745759
[TBL] [Abstract][Full Text] [Related]
13. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride.
Toti US; Aminabhavi TM
J Control Release; 2004 Mar; 95(3):567-77. PubMed ID: 15023467
[TBL] [Abstract][Full Text] [Related]
14. Swellable matrices for the controlled-release of diclofenac sodium: formulation and in vitro studies.
Bravo SA; Lamas MC; Salomon CJ
Pharm Dev Technol; 2004; 9(1):75-83. PubMed ID: 15000468
[TBL] [Abstract][Full Text] [Related]
15. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
Savaşer A; Ozkan Y; Işimer A
Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
[TBL] [Abstract][Full Text] [Related]
17. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
[TBL] [Abstract][Full Text] [Related]
18. An innovative matrix controlling drug delivery produced by thermal treatment of DC tablets containing polycarbophil and ethylcellulose.
Caviglioli G; Baldassari S; Cirrincione P; Russo E; Parodi B; Gatti P; Drava G
Int J Pharm; 2013 Dec; 458(1):74-82. PubMed ID: 24144954
[TBL] [Abstract][Full Text] [Related]
19. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
[TBL] [Abstract][Full Text] [Related]
20. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
